Imidazolium salts as novel anti-liver fibrosis agents

被引：0
|
作者：
Zhuo, L. [1 ]
Zhang, C. [1 ]
Ding, Z. B. [1 ]
Kng, Y. L. [1 ]
Suhaimi, N-A M. [1 ]
Zhang, Y. G. [1 ]
机构：
[1] The Nanos, Inst Bioengn & Nanotechnol, Singapore, Singapore
来源：
JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY | 2009年 / 24卷
关键词：
D O I：
暂无
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
引用
收藏
页码：A142 / A142
页数：1
相关论文
共 50 条
  • [31] Development of a novel anti-liver fibrosis formula with luteolin, licochalcone A, aloe-emodin and acacetin by network pharmacology and transcriptomics analysis
    Zhou, Yuan
    Wu, Rong
    Cai, Fei-fei
    Zhou, Wen-Jun
    Lu, Yi-Yu
    Zhang, Hui
    Chen, Qi-Long
    Sun, Ming-Yu
    Su, Shi-Bing
    PHARMACEUTICAL BIOLOGY, 2021, 59 (01) : 1594 - 1606
  • [32] Research progress of natural compounds in anti-liver fibrosis by affecting autophagy of hepatic stellate cells
    Yongxiang Shu
    Xuyou Liu
    Haifeng Huang
    Qi Wen
    Jianchang Shu
    Molecular Biology Reports, 2021, 48 : 1915 - 1924
  • [33] Mechanistic studies of imidazolium salts as antitumor agents
    Southerland, Marie
    Wagers, Patrick
    DeBord, Michael
    Shelton, Kerri
    Shriver, Leah
    Paruchuri, Sailaja
    Tessier, Claire
    Panzner, Matthew
    Youngs, Wiley
    ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY, 2015, 249
  • [34] Study on the Anti-Liver Fibrosis Effect of Benefit Liver Granule (益肝冲剂) and Its Mechanism in Rats
    姚希贤
    冯丽英
    崔东来
    孙泽民
    孙玉凤
    宋梅
    Chinese Journal of Integrated Traditional and Western Medicine, 2002, (02) : 118 - 121+161
  • [35] Synthesis, biological activity evaluation and mechanism of action of novel bis-isatin derivatives as potential anti-liver cancer agents
    Li, Zhifen
    Ma, Jingbo
    Tian, Ming
    Xia, Peng
    Lv, Xiannian
    Hou, Rui
    Jiang, Yuke
    Xu, Xiaolong
    Jia, Zhifang
    Wang, Jigang
    Li, Zhijie
    BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 2024, 99
  • [36] A combination of astragaloside I, levistilide A and calycosin exerts anti-liver fibrosis effects in vitro and in vivo
    Tao Guo
    Zu-long Liu
    Qiang Zhao
    Zhi-min Zhao
    Cheng-hai Liu
    Acta Pharmacologica Sinica, 2018, 39 : 1483 - 1492
  • [37] A combination of astragaloside I, levistilide A and calycosin exerts anti-liver fibrosis effects in vitro and in vivo
    Guo, Tao
    Liu, Zu-long
    Zhao, Qiang
    Zhao, Zhi-min
    Liu, Cheng-hai
    ACTA PHARMACOLOGICA SINICA, 2018, 39 (09) : 1483 - 1492
  • [38] Research progress of natural compounds in anti-liver fibrosis by affecting autophagy of hepatic stellate cells
    Shu, Yongxiang
    Liu, Xuyou
    Huang, Haifeng
    Wen, Qi
    Shu, Jianchang
    MOLECULAR BIOLOGY REPORTS, 2021, 48 (02) : 1915 - 1924
  • [39] FIXATION OF SPECIFIC ANTI-LIVER ANTIBODIES IN RAT
    EDGINGTO.TS
    FEDERATION PROCEEDINGS, 1966, 25 (2P1) : 473 - &
  • [40] Tetrodecadazinone, a novel tetrodecamycin-pyridazinone hybrid with anti-liver fibrosis activity from Streptomyces sp. HU051
    Liu, Ruo-Xi
    Ma, Shi-Fan
    Chen, Yi-Li
    Ma, Lie-Feng
    Wang, Ji-Dong
    Zhan, Zha-Jun
    BIOORGANIC CHEMISTRY, 2022, 119
12345